Invasive aspergillosis associated with severe influenza infections

Open Forum Infectious Diseases

Volumn 3, Issue 3, 2016, Pages

  Crum Cianflone, Nancy F ^a,b  

^a SCRIPPS MERCY HOSPITAL   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

Aspergillosis; Aspergillus; Influenza; Review; Superinfection

Indexed keywords

GALACTOMANNAN; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; MICAFUNGIN; OSELTAMIVIR; PERAMIVIR; PREDNISONE; VORICONAZOLE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ALLERGY; ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS VERSICOLOR; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CASE CONTROL STUDY; CAUSE OF DEATH; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA B; INVASIVE ASPERGILLOSIS; LYMPHOCYTOPENIA; MALE; MEDICAL INTENSIVE CARE UNIT; MIDDLE AGED; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SEPSIS; SUPERINFECTION; VERY ELDERLY;

EID: 85016068290     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofw171     Document Type: Article

References (46)

1. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198:962-70.
2. Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008; 122:805-11.
3. Lee JY, Joo EJ, Yeom JS, et al. Aspergillus tracheobronchitis and influenza A coinfection in a patient with AIDS and neutropenia. Infect Chemother 2014; 46:209-15.
4. Lat A, Bhadelia N, Miko B, et al. Invasive aspergillosis after pandemic (H1N1) 2009 Emerg Infect Dis 2010; 16:971-3.
5. Astry CL, Jakab GJ. Influenza virus-induced immune complexes suppress alveolar macrophage phagocytosis. J Virol 1984; 50:287-92.
6. Small CL, Shaler CR, McCormick S, et al. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung. J Immunol 2010; 184:2048-56.
7. Barthelemy A, Ivanov S, Fontaine J, et al. Influenza A virus-induced release of interleukin-10 inhibits the anti-microbial activities of invariant natural killer T cells during invasive pneumococcal superinfection. Mucosal Immunol 2016; doi:10.1038/mi.2016.49.
8. Ghoneim HE, Thomas PG, McCullers JA. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J Immunol 2013; 191:1250-9.
9. Fox A, Le NM, Horby P, et al. Severe pandemic H1N1 2009 infection is associated with transient NK and T deficiency and aberrant CD8 responses. PLoS One 2012; 7:e31535.
10. Mohan SS, McDermott BP, Cunha BA. The diagnostic and prognostic significance of relative lymphopenia in adult patients with influenza A. Am J Med 2004; 117:710-1.
11. Cunha BA, Pherez FM, Schoch P. Diagnostic importance of relative lymphopenia as a marker of swine influenza (H1N1) in adults. Clin Infect Dis 2009; 49:1454-6.
12. Martin-Loeches I, Lisboa T, Rhodes A, et al. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med 2011; 37:272-83.
13. Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. Lancet 2003; 362:1828-38.
14. Wauters J, Baar I, Meersseman P, et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med 2012; 38:1761-8.
15. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46:1813-21.
16. Alshabani K, Haq A, Miyakawa R, et al. Invasive pulmonary aspergillosis in patients with influenza infection: report of two cases and systematic review of the literature. Expert Rev Respir Med 2015; 9:89-96.
17. Kwon OK, Lee MG, Kim HS, et al. Invasive pulmonary aspergillosis after influenza A infection in an immunocompetent patient. Tuberc Respir Dis (Seoul) 2013; 75:260-3.
18. Kim MJ, Kim MK, Kang CK, et al. A case of acute cerebral aspergillosis complicating influenza A/H1N1pdm 2009. Infect Chemother 2013; 45: 225-9.
19. Yildirim Y, Pecha S, Sill B, et al. Severe bacterial superinfection based on influenza A (H1N1) pneumonia in a heart-lung transplant recipient. Thorac Cardiovasc Surg 2013; 61:255-7.
20. Toh HS, Jiang MY, Tay HT. Invasive pulmonary aspergillosis in severe complicated influenza A. J Formos Med Assoc 2013; 112:810-1.
21. Otterspoor LC, Smit FH, van Laar TJ, et al. Prolonged use of extracorporeal membrane oxygenation combined with prone positioning in patients with acute respiratory distress syndrome and invasive Aspergillosis. Perfusion 2012; 27:335-7.
22. Vehreschild JJ, Bröckelmann PJ, Bangard C, et al. Pandemic 2009 influenza A (H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients. Epidemiol Infect 2012; 140:1848-52.
23. Hoyo-Ulloa I, Cobos-Trigueros N, Puig-de la Bellacasa J, Martínez-Martínez JA. Influenza A (H1N1) complicated by invasive aspergillosis in non-severely immunocompromised patients. Enferm Infecc Microbiol Clin 2012; 30:583-4.
24. Guervilly C, Roch A, Ranque S, et al. A strategy based on galactomannan antigen detection and PCR for invasive pulmonary aspergillosis following influenza A (H1N1) pneumonia. J Infect 2012; 65:470-3.
25. Adalja AA, Sappington PL, Harris SP, et al. Isolation of Aspergillus in three 2009 H1N1 influenza patients. Influenza Other Respir Viruses 2011; 5:225-9.
26. Kim SH, Kim MN, Lee SO, et al. Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis. Mycoses 2012; 55:189-92.
27. Garcia-Vidal C, Barba P, Arnan M, et al. Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients. Clin Infect Dis 2011; 53:e16-9.
28. Carfagna P, Brandimarte F, Caccese R, et al. Occurrence of influenza A(H1N1)v infection and concomitant invasive pulmonary aspergillosis in a patient with chronic obstructive pulmonary disease. Mycoses 2011; 54:549-51.
29. Passouant O, Mateu P, Commandini M, et al. Pulmonary aspergillosis in non-immunocompromised patient with acute respiratory distress syndrome during A (H1N1) infection. Ann Fr Anesth Reanim 2011; 30:e75-6.
30. Helbig G, Wozniczka K, Wieczorkiewicz A, et al. Irreversible marrow aplasia after single course of 2-chlorodeoxyadenosine for hairy cell leukaemia preceding by A pandemic 2009-H1N1-associated pneumonia. Med Oncol 2011; 28:1601-3.
31. Hasejima N, Yamato K, Takezawa S, et al. Invasive pulmonary aspergillosis associated with influenza B. Respirology 2005; 10:116-9.
32. Lee FE, Daigle CC, Urban MA, et al. Fever and progressive respiratory failure in three elderly family members. Chest 2005; 128:1863-4, 1865-7.
33. Boots RJ, Paterson DL, Allworth AM, Faoagali JL. Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF. Thorax 1999; 54:1047-9.
34. Hovenden JL, Nicklason F, Barnes RA. Invasive pulmonary aspergillosis in nonimmunocompromised patients. BMJ 1991; 302:583-4.
35. Lewis M, Kallenbach J, RuffP, Zaltzman M, et al. Invasive pulmonary aspergillosis complicating influenza A pneumonia in a previously healthy patient. Chest 1985; 87:691-3.
36. Horn CR, Wood NC, Hughes JA. Invasive aspergillosis following post-influenzal pneumonia. Br J Dis Chest 1983; 77:407-10.
37. McLeod DT, Milne LJ, Seaton A. Successful treatment of invasive pulmonary aspergillosis complicating influenza A. Br Med J (Clin Res Ed) 1982; 285:1166-7.
38. Fischer JJ, Walker DH. Invasive pulmonary aspergillosis associated with influenza. JAMA 1979; 241:1493-4.
39. Guarner J, Falcón-Escobedo R. Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses. Arch Med Res 2009; 40:655-61.
40. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 InfluenzaBautista E, Chotpitayasunondh T, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010; 362:1708-19.
41. Wilson R, Alton E, Rutman A, et al. Upper respiratory tract viral infection and mucociliary clearance. Eur J Respir Dis 1987; 70:272-9.
42. Lee N, Wong CK, Chan PK, et al. Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults. PLoS One 2011; 6: e26050.
43. Shi S, Li H, Liu M, et al. Mortality prediction to hospitalized patients with influenza pneumonia: PO2/FiO2 combined lymphocyte count is the answer. Clin Respir J 2015; doi:10.111/crj.12346.
44. Diaz E, Martin-Loeches I, Canadell L, et al. Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza. J Infect 2012; 64:311-8.
45. Park SY, Lim C, Lee SO, et al. Computed tomography findings in invasive pulmonary aspergillosis in non-neutropenic transplant recipients and neutropenic patients, and their prognostic value. J Infect 2011; 63:447-56.
46. Muller MP, McGeer AJ, Hassan K, et al. Evaluation of pneumonia severity and acute physiology scores to predict ICU admission and mortality in patients hospitalized for influenza. PLoS One 2010; 5:e9563.